BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37608964)

  • 21. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
    Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
    Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
    J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.
    Schmitz S; Machiels JP; Weynand B; Gregoire V; Hamoir M
    Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):437-43. PubMed ID: 18648835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of postoperative radiation therapy for regional control after dissection in head and neck squamous cell carcinoma cases.
    Li XM; Di B; Shang YD; Tao ZF; Cheng JM; He ZG
    Asian Pac J Cancer Prev; 2013; 14(7):4273-8. PubMed ID: 23991989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.
    Ang KK; Trotti A; Brown BW; Garden AS; Foote RL; Morrison WH; Geara FB; Klotch DW; Goepfert H; Peters LJ
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):571-8. PubMed ID: 11597795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of time between surgery and adjuvant radiotherapy on prognosis for patients with head and neck squamous cell carcinoma: A systematic review.
    Sun K; Tan JY; Thomson PJ; Choi SW
    Head Neck; 2023 Aug; 45(8):2108-2119. PubMed ID: 37194205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1).
    Alsharif U; Steller D; Falougy M; Tharun L; Rades D; Hakim SG
    Anticancer Res; 2022 Jan; 42(1):97-104. PubMed ID: 34969714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
    Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
    Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
    Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
    Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.
    Tawk B; Wirkner U; Schwager C; Rein K; Zaoui K; Federspil PA; Adeberg S; Linge A; Ganswindt U; Hess J; Unger K; Tinhofer I; Budach V; Lohaus F; Krause M; Guberina M; Stuschke M; Balermpas P; Rödel C; Grosu AL; Schäfer H; Zips D; Combs SE; Pigorsch S; Zitzelsberger H; Baumeister P; Kirchner T; Bewerunge-Hudler M; Weichert W; Hess J; Herpel E; Belka C; Baumann M; Debus J; Abdollahi A;
    Int J Cancer; 2022 Feb; 150(4):603-616. PubMed ID: 34648658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival.
    Butkus JM; Crippen M; Bar-Ad V; Luginbuhl A
    Front Oncol; 2022; 12():973245. PubMed ID: 36248977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Graboyes EM; Zhan KY; Garrett-Mayer E; Lentsch EJ; Sharma AK; Day TA
    Cancer; 2017 Jun; 123(12):2248-2257. PubMed ID: 28182267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Chen MM; Harris JP; Hara W; Sirjani D; Divi V
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1224-1230. PubMed ID: 27832255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.
    Hosni A; Huang SH; Chiu K; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; Yu E; de Almeida JR; Monteiro E; Chepeha DB; Irish JC; Goldstein DP; Hope A
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):363-373. PubMed ID: 30244160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of second hand smoke in patients with squamous cell carcinoma of the head and neck.
    Idris S; Baqays A; Isaac A; Chau JKM; Calhoun KH; Seikaly H
    J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):33. PubMed ID: 31337433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.